Nuvation Bio
NUVB
4.86
-0.02
-0.41%
Nuvation Bio
US · NUVB
#2898 by market cap
Listed 1970
4.86
-0.02
-0.41%
Live - 5344 symbols - heartbeat 468s ago
· 2026-10-08 08:12
Pre-market
4.81
-1.03%
After-hours
4.95
+1.85%
Overnight
4.82
-0.82%
- Market cap
- 1.71B
- P/E (TTM)i
- -11.05
- P/Bi
- 6.72
- EPSi
- -0.60
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on NUVB?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
14.57 +199.8%
Price target rangecurrent 4.86
Low11.00
Avg14.57
High21.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | Citi | -- | BUY | 12.00 |
| 2026-09-30 | Citi | -- | BUY | 12.00 |
| 2026-09-15 | Truist Financial | -- | BUY | -- |
| 2026-09-15 | Wedbush | -- | BUY | 11.00 |
| 2026-09-15 | J.P. Morgan | -- | BUY | -- |
| 2026-08-21 | Cantor Fitzgerald | -- | BUY | 12.00 |
| 2026-08-18 | J.P. Morgan | -- | BUY | 13.00 |
| 2026-08-07 | Truist Financial | -- | BUY | 13.00 |
| 2026-08-07 | B. Riley Securities | -- | BUY | 14.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-08-06 | JonesTrading | -- | BUY | 12.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 20.00 |
| 2026-07-28 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-07-27 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-07-21 | Truist Financial | -- | BUY | -- |
| 2026-07-21 | Wedbush | -- | BUY | 11.00 |
| 2026-07-20 | JonesTrading | -- | BUY | 12.00 |
| 2026-07-20 | RBC Capital | -- | BUY | 19.00 |
| 2026-07-08 | Truist Financial | -- | BUY | 13.00 |
| 2026-07-07 | RBC Capital | -- | BUY | 19.00 |
| 2026-06-30 | Wedbush | -- | BUY | 11.00 |
| 2026-06-10 | Truist Financial | -- | BUY | -- |
| 2026-06-01 | TD Cowen | -- | BUY | -- |
| 2026-05-26 | H.C. Wainwright | -- | BUY | 17.00 |
| 2026-05-21 | B. Riley Securities | -- | BUY | 12.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±23.60% | -4.08% (in line) |
| 2026/Q1 | 2026-05-04 | After close | ±18.14% | +9.52% (in line) |
| 2025/Q4 | 2026-03-02 | After close | ±30.45% | -25.34% (in line) |
| 2025/Q3 | 2025-11-03 | After close | ±24.18% | -6.58% (in line) |
| 2025/Q2 | 2025-08-07 | -- | ±18.72% | -0.43% (in line) |
| 2025/Q1 | 2025-05-07 | After close | ±24.51% | +2.94% (in line) |
| 2022/Q1 | 2022-05-09 | -- | -- | -6.21% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:12:59 · For reference only, not investment advice and not tailored to your situation.